Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms

References

• Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547–61
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325–32
   PubMed Web of Science ®Google Scholar
• Brenner DM, Moeller MJ, Chey WD, et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2010;104:1033–49
   Web of Science ®Google Scholar
• Zhang Y, Li L, Guo C, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol 2016;16:62
   PubMed Web of Science ®Google Scholar
• Yuan F, Ni H, Asche CV, et al. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Curr Med Res Opin 2017;1–17
   Web of Science ®Google Scholar
• Charbonneau D, Gibb RD, Quigley EM. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013;4:201–11
   PubMed Web of Science ®Google Scholar
• O’Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541–51
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101:1581–90
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005;17:687–96
   PubMed Web of Science ®Google Scholar
• Cappello C, Tremolaterra F, Pascariello A, et al. A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life. Int J Colorectal Dis 2013;28:349–58
   PubMed Web of Science ®Google Scholar
• Lewis ZT, Shani G, Masarweh CF, et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res 2016;79:445–52
   PubMed Web of Science ®Google Scholar
• Altmann F, Kosma P, O’Callaghan A, et al. Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp. longum 35624™. PLoS One 2016;11:e0162983
   PubMed Web of Science ®Google Scholar
• Hill C, Scott K, Klaenhammer T, et al. Probiotic nomenclature matters. Gut Microbes 2016;7:1–2
   PubMed Web of Science ®Google Scholar
• Mazurak N, Broelz E, Storr M, et al. Probiotic therapy of the irritable bowel syndrome: why is the evidence still poor and what can be done about it? J Neurogastroenterol Motil 2015;21:471–85
   PubMed Web of Science ®Google Scholar
• Whelan K. Editorial: the importance of systematic reviews and meta-analyses of probiotics and prebiotics. Am J Gastroenterol 2014;109:1563–5
   PubMed Web of Science ®Google Scholar
• Allen AP, Dinan TG, Clarke G, et al. A psychology of the human brain-gut-microbiome axis. Soc Personal Psychol Compass. 2017;11:e12309
   PubMed Web of Science ®Google Scholar
• Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 2006;40:264–9
   PubMed Web of Science ®Google Scholar
• Wall R, Cryan JF, Ross RP, et al. Bacterial neuroactive compounds produced by psychobiotics. In: Lyte M, Cryan JF, editors. Microbial endocrinology: The microbiota-gut-brain axis in health and disease. New York: Springer; 2014. p 221–39
   Google Scholar
• Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657–64
   PubMed Web of Science ®Google Scholar
• Desbonnet L, Garrett L, Clarke G, et al. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008;43:164–74
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: a meta-analysis of randomized controlled trials. Arch Med Sci 2008;4:71–6
   Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015;161:264–76
   PubMed Web of Science ®Google Scholar
• Moloney RD, O’Mahony SM, Dinan TG, et al. Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatr 2015;16:15
   Google Scholar
• Allen AP, Hutch W, Borre YE, et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatr 2016;6:e939
   PubMed Web of Science ®Google Scholar
• Savignac HM, Kiely B, Dinan TG, et al. Bifidobacteria exert strain‐specific effects on stress‐related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 2014;26:1615–27
   PubMed Web of Science ®Google Scholar
• Savignac HM, Tramullas M, Kiely B, et al. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res 2015;287:59–72
   PubMed Web of Science ®Google Scholar
• Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci 2011;108:16050–5
   PubMed Web of Science ®Google Scholar
• Kelly JR, Allen AP, Temko A, et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 2016;61:50–9
   PubMed Web of Science ®Google Scholar
• Fond G, Loundou A, Hamdani N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatr Clin Neurosci 2014;264:651–60
   PubMed Web of Science ®Google Scholar